Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer

Dingwei Diao(Nanfang Hospital), Kaican Cai(Nanfang Hospital)

Translational Lung Cancer Research

February 1, 2021

10.21037/tlcr-21-144

Cited by 10

Related Papers

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

|JAMA|2024|359

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study

|PLoS ONE|2015|206

Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial

|Cancer Cell|2024|58

<p>Circular RNA circNELL2 Acts as the Sponge of miR-127-5p to Promote Esophageal Squamous Cell Carcinoma Progression</p>

|OncoTargets and Therapy|2020|25

Safety and efficacy of aprepitant as mono and combination therapy for the prevention of emetogenic chemotherapy-induced nausea and vomiting: post-marketing surveillance in China

|Chinese Clinical Oncology|2020|8